The state Board of Education, controlled by Republicans, is on the verge of requiring millions of students in Texas to study ...
Although the path may be demanding and might stretch us toward new ways to pray, preaching Habakkuk can help not only the ...
Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...
Mezigdomide (a CELMoD) combined with carfilzomib/dexamethasone met the phase 3 primary end point, delivering statistically significant, clinically meaningful PFS ...
The FDA plans to drop its long-standing requirement that drugmakers conduct two rigorous studies to secure approval for new drugs and is also pushing to expand over-the-counter access to medications.
(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on prostate cancer, and a presentation by Dr. Daniel Petrylak discussing initial results of a ...
CD40 agonist mitazalimab + mFOLFIRINOX (mFFX) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final efficacy analysis of the OPTIMIZE-1 study. This is an ASCO Meeting Abstract ...
Nab-paclitaxel plus gemcitabine (AG) is the standard first-line chemotherapy for advanced or metastatic pancreatic ductal adenocarcinoma and has limited efficacy. This phase 1b/2 study aimed to ...
Carotid artery stenting combined with medical therapy demonstrated a significantly lower stroke risk compared to intensive medical therapy alone in patients with severe asymptomatic carotid stenosis ...
SAN FRANCISCO and SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
The Transportation Authority in collaboration with the SFMTA is conducting the District 2 Safety Study to address traffic safety and access challenges to places that attract seniors, children, and ...
William Blair analysts said in a note to investors that they “are unsurprised by the result" of a phase 2 study of Vigil Neuroscience’s iluzanebart. (iStock / Getty Images Plus) A phase 2 study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results